Glenmark Pharmaceuticals informs about press release
Date: 21-01-2016Glenmark Pharmaceuticals has informed about a Press Release dated January 21, 2016 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Capsules USP, 10 mEq’.
The above information is a part of company’s filings submitted to BSE.